Cell and Gene Therapy, Industry
March 25, 2021
Via: BioSpaceOn the back of a $135 million public offering in February, rare disease gene therapy company Krystal Biotech has launched subsidiary Jeune Inc. to promote its gene therapies for aesthetic skin conditions. In conjunction with the launch, Jeune announced positive […]
July 11, 2024
July 19, 2024
July 11, 2024